Francis M. Cuss, Director at Rubius Therapeutics, Inc. (RUBY), bought 10,000 shares at $23.00 ($230K) on 2018-07-20, disclosed to the SEC on 2018-07-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| BMY | SELL | 2014-02-18 | $1.6M | — | Filing → |
| BMY | SELL | 2013-03-14 | $2.7M | — | Filing → |
| BMY | SELL | 2012-09-04 | $3.9M | — | Filing → |